학술논문

SOLTI-1910: Predicting olaparib sensitivity in patients with unresectable locally advanced/metastatic HER2-negative breast cancer with BRCA1/2, PALB2, RAD51C/D mutations or HRD by the RAD51 test: RADIOLA TRIAL
Document Type
Journal
Source
CANCER RESEARCH; MAR 1 2023, 83 5, 3p. Supplement: S
Subject
Language
English
ISSN
15387445